Shojaeefar, Ehsan, et al. “What We Know so Far about Myxovirus Resistance Protein A (MxA) As a Biomarker of Interferon-Beta Therapy in Patients With Multiple Sclerosis: A Systematic Review”. Archives of Men’s Health, vol. 3, no. 1, Dec. 2020, p. e19, doi:10.22037/mhj.v3i1.33124.